ABYS® MEDICAL successfully completes its first Series A of €3 million
3 December 2021Abys® Medical, deeptech creator of the Surgery 4.0 concept, finalized in August 2021 a fundraising by opening its capital to... View Article
Valneva confirms initiation of rolling review with EMA and provides updates on its COVID-19 vaccine program VLA2001
Valneva, a specialty vaccine company, today confirmed that the European Medicines Agency (EMA) has started a rolling review of VLA2001,... View Article
New member | Healshape
1 December 2021Healshape is a regenerative medicine company with the mission to offer the enhanced option of self-tissue regeneration from patient’s own... View Article